OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Point-of-care urine tenofovir testing to predict HIV drug resistance among individuals with virologic failure
Suzanne M. McCluskey, Katya Govender, John Adamson, et al.
AIDS (2023) Vol. 37, Iss. 7, pp. 1109-1113
Closed Access | Times Cited: 12
Suzanne M. McCluskey, Katya Govender, John Adamson, et al.
AIDS (2023) Vol. 37, Iss. 7, pp. 1109-1113
Closed Access | Times Cited: 12
Showing 12 citing articles:
Acceptability and perspectives on clinic-based urine tenofovir testing for antiretroviral therapy adherence monitoring: qualitative findings from a randomized controlled trial in South Africa
Ashley R. Bardon, Makhosazane Zondi, Jane M. Simoni, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Ashley R. Bardon, Makhosazane Zondi, Jane M. Simoni, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Point-of-care urine tenofovir monitoring of adherence to drive interventions for HIV treatment and prevention
Matthew A. Spinelli, Monica Gandhi
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 3, pp. 169-175
Closed Access | Times Cited: 2
Matthew A. Spinelli, Monica Gandhi
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 3, pp. 169-175
Closed Access | Times Cited: 2
Diagnostic accuracy of a point‐of‐care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz‐based antiretroviral therapy
Jienchi Dorward, Richard Lessells, Katya Govender, et al.
Journal of the International AIDS Society (2023) Vol. 26, Iss. 9
Open Access | Times Cited: 5
Jienchi Dorward, Richard Lessells, Katya Govender, et al.
Journal of the International AIDS Society (2023) Vol. 26, Iss. 9
Open Access | Times Cited: 5
Detection and quantification of antiviral drug tenofovir using silver nanoparticles and surface enhanced Raman spectroscopy (SERS) with spatially resolved hotspot selection
M. Butler, Jana Hrnčířová, Terry A. Jacot, et al.
Frontiers in Nanotechnology (2023) Vol. 5
Open Access | Times Cited: 4
M. Butler, Jana Hrnčířová, Terry A. Jacot, et al.
Frontiers in Nanotechnology (2023) Vol. 5
Open Access | Times Cited: 4
Low-cost urine tenofovir assay to triage dolutegravir resistance testing
Tyler Martinson, Jacinta Nwogu-Attah, Matthew A. Spinelli, et al.
The Lancet HIV (2024) Vol. 11, Iss. 5, pp. e282-e283
Closed Access | Times Cited: 1
Tyler Martinson, Jacinta Nwogu-Attah, Matthew A. Spinelli, et al.
The Lancet HIV (2024) Vol. 11, Iss. 5, pp. e282-e283
Closed Access | Times Cited: 1
Quantification of Antiviral Drug Tenofovir (TFV) by Surface-Enhanced Raman Spectroscopy (SERS) Using Cumulative Distribution Functions (CDFs)
M. Butler, Jana Hrnčířová, Meredith R. Clark, et al.
ACS Omega (2023) Vol. 9, Iss. 1, pp. 1310-1319
Open Access | Times Cited: 3
M. Butler, Jana Hrnčířová, Meredith R. Clark, et al.
ACS Omega (2023) Vol. 9, Iss. 1, pp. 1310-1319
Open Access | Times Cited: 3
Comparing a point‐of‐care urine tenofovir lateral flow assay to self‐reported adherence and their associations with viral load suppression among adults on antiretroviral therapy
Tamsin K. Phillips, Yolanda Gomba, Landon Myer
Tropical Medicine & International Health (2023) Vol. 29, Iss. 2, pp. 96-103
Open Access | Times Cited: 2
Tamsin K. Phillips, Yolanda Gomba, Landon Myer
Tropical Medicine & International Health (2023) Vol. 29, Iss. 2, pp. 96-103
Open Access | Times Cited: 2
Diagnostic accuracy of a point-of-care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz-based antiretroviral therapy
Jienchi Dorward, Richard Lessells, Katya Govender, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Jienchi Dorward, Richard Lessells, Katya Govender, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Urine tenofovir and dried blood spot tenofovir diphosphate concentrations and viraemia in people taking efavirenz and dolutegravir-based antiretroviral therapy
Jienchi Dorward, Katya Govender, Pravi Moodley, et al.
AIDS (2023) Vol. 38, Iss. 5, pp. 697-702
Open Access | Times Cited: 1
Jienchi Dorward, Katya Govender, Pravi Moodley, et al.
AIDS (2023) Vol. 38, Iss. 5, pp. 697-702
Open Access | Times Cited: 1
Point-of-care urine tenofovir test predicts future HIV preexposure prophylaxis discontinuation among young users
Tyler Martinson, R Teruel Montoya, Carlos Henrique Valente Moreira, et al.
AIDS (2024) Vol. 38, Iss. 11, pp. 1671-1676
Closed Access
Tyler Martinson, R Teruel Montoya, Carlos Henrique Valente Moreira, et al.
AIDS (2024) Vol. 38, Iss. 11, pp. 1671-1676
Closed Access
The Impact of Adherence Counselling Incorporating a Point of Care Urine Tenofovir Assay on Virologic Suppression among Individuals Failing Tenofovir-Lamivudine-Dolutegravir: A Pre - Post intervention Study
Leonard Bikinesi, Matthew A. Spinelli, Ntombizodwa Nyoni, et al.
International Journal of Infectious Diseases (2024), pp. 107328-107328
Open Access
Leonard Bikinesi, Matthew A. Spinelli, Ntombizodwa Nyoni, et al.
International Journal of Infectious Diseases (2024), pp. 107328-107328
Open Access
Point-of-care urine tenofovir testing: making a good thing better
Mauro Zaccarelli, Bienvenu Niyongabo, Brian Conway
AIDS (2023) Vol. 37, Iss. 7, pp. 1159-1160
Closed Access
Mauro Zaccarelli, Bienvenu Niyongabo, Brian Conway
AIDS (2023) Vol. 37, Iss. 7, pp. 1159-1160
Closed Access
